David Brook
academic
David Brook collaborated with Peter Singer on modeling the effects of global access to GLP-1 medicines, which highlight the potential to save millions of lives annually from diabetes and obesity-related complications.
Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
29,145
Power
1,304$
Sentiment
6.00
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Canada | 1 | 6.00 | 0.08% | +0% | 38,005,238 | 29,145 | $1,700,000 | 1,304$ |
| Totals | 1 | 38,005,238 | 29,145 | $1,700,000 | 1,304$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
In a preprint estimate in collaboration with David Brook, Dr. Singer modelled the effects of global access to these GLP-1 medicines.
6